India Azithromycin Market to grow at a steady rate During the Forecast Period
Growing prevalence of
respiratory problems is expected to drive the growth of India azithromycin
market.
According
to TechSci Research report, “India Azithromycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Powder, Solution/Drops),
By Route of Administration (Oral, Injectable, Ophthalmic), By Distribution
Channel (Online v/s Offline), By Application (Middle Ear Infections, Strep
Throat, Pneumonia, Travelers Diarrhea, Sexually Transmitted Infections, Others),
By End User (Adult v/s Pediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, the India azithromycin market
is expected to grow at a steady rate during the forecast period on account of the
growing prevalence of bacterial infections. Azithromycin is an antibacterial
antibiotic which functions by stopping the synthesis of important proteins that
are required for the growth of bacteria and are essential for it to carry out
vital functions inside the human body. In this way, the drug prevents bacterial
growth and infection spread across the body. The drug has a long serum half-life
and is able to resist several bacteria, even those belonging to the
streptococcus family. Azithromycin is used in combination with the
anti-malarial drug hydroxychloroquine for the treatment of patients suffering
from COVID-19. This in turn is expected to fuel the market growth through
FY2026. Besides, the drug is helpful in fighting a range of respiratory
infections including mild to moderate lung infections, sinuses, pneumonia,
among others. However, side-effects associated with drug consumption such as
nausea, vomiting, abdominal pain, diarrhea and stomach infection can restrict
the market growth over the next few years. This can further reduce the usage
and application of the drug thereby hindering the market growth.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" India
azithromycin market "
https://www.techsciresearch.com/report/india-azithromycin-market/5138.html
The India azithromycin market is segmented based on source, form, route
of administration, distribution channel, application, end user, company and
region. Based on form, the market can be fragmented into tablets, powder and
solution/drops. The tablets segment is expected to dominate the market on
account of their self-administration, patient compliance and cost-effectiveness.
Based on route of administration, the market can be categorized into oral,
injectable and ophthalmic. The oral route is expected to dominate the market
since this is the simplest, pain free and easy to take route of drug administration.
Additionally, when a drug is taken orally the absorption takes place along the
complete length of gastrointestinal tract.
Pfizer Limited, Lupin Limited, Aurobindo Pharma Limited, Alembic
Pharmaceuticals, Jubilant Life Sciences Limited, Sandoz Private Limited,
Century Pharmaceuticals Limited, Infinity Laboratories Pvt. Ltd., Anuh Pharma
Ltd., Farmachem Life Pvt Ltd., Envee Drugs Pvt. Ltd. and others are some of the
leading players operating in India azithromycin market. Companies operating in
the market are using organic strategies such as product launches, mergers and
collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5138
Customers can also
request for 10% free customization on this report.
“India azithromycin market is expected to
witness growth during the forecast period on account of the Pharma Vision 2020
announced by the government of India. With the goal of making India a global
leader in not only generic medicine production but also an end to end leader in
drug discovery and development this vision was put forth. Furthermore, the
China plus one strategy to stop dependency on imports from China and making
investments in China for drugs, intermediates and APIs is further expected to
fuel the market growth through FY2026. Also, various schemes were launched to
promote drug development and discovery indigenously through the network of
local manufacturers amidst the Indo-China border escalations and COVID-19 which
are further expected to create lucrative opportunities for the market growth over
the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Azithromycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Powder, Solution/Drops),
By Route of Administration (Oral, Injectable, Ophthalmic), By Distribution
Channel (Online v/s Offline), By Application (Middle Ear Infections, Strep
Throat, Pneumonia, Travelers Diarrhea, Sexually Transmitted Infections, Others),
By End User (Adult v/s Pediatric), By Company, By Region, Forecast &
Opportunities, FY2026”, has
evaluated the future growth potential of India azithromycin market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India azithromycin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]